APA (7th ed.) Citation

Eichhorn, S., Pili, R., Epstein, J. B., Rajesh, R., & Satheeshkumar, P. S. (2025). Receiving immunotherapy for the treatment of advanced renal cell carcinoma is associated with higher burden of illness, coagulopathy, cardiac arrhythmia, and disparities. Supportive Care in Cancer, 33(4), . https://doi.org/10.1007/s00520-025-09353-5

Chicago Style (17th ed.) Citation

Eichhorn, Susan, Roberto Pili, Joel B. Epstein, Richa Rajesh, and Poolakkad S. Satheeshkumar. "Receiving Immunotherapy for the Treatment of Advanced Renal Cell Carcinoma Is Associated with Higher Burden of Illness, Coagulopathy, Cardiac Arrhythmia, and Disparities." Supportive Care in Cancer 33, no. 4 (2025). https://doi.org/10.1007/s00520-025-09353-5.

MLA (9th ed.) Citation

Eichhorn, Susan, et al. "Receiving Immunotherapy for the Treatment of Advanced Renal Cell Carcinoma Is Associated with Higher Burden of Illness, Coagulopathy, Cardiac Arrhythmia, and Disparities." Supportive Care in Cancer, vol. 33, no. 4, 2025, https://doi.org/10.1007/s00520-025-09353-5.